BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1901312)

  • 1. Synthesis and antibacterial activity of new C-10 quinolonyl-cephem esters.
    Demuth TP; White RE; Tietjen RA; Storrin RJ; Skuster JR; Andersen JA; McOsker CC; Freedman R; Rourke FJ
    J Antibiot (Tokyo); 1991 Feb; 44(2):200-9. PubMed ID: 1901312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
    Washington JA II
    J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on antibacterial agents. III. Synthesis and antibacterial activities of substituted 1,4-dihydro-8-methyl-4-oxoquinoline-3-carboxylic acids.
    Miyamoto H; Ueda H; Otsuka T; Aki S; Tamaoka H; Tominaga M; Nakagawa K
    Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2472-5. PubMed ID: 1962740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antibacterial activity of 7 beta-[1-(2-aminothiazol-4-yl)-1-cyclopropanecarboxyamido]cephem derivatives.
    Nishimura S; Yasuda N; Sasaki H; Sakane K; Takaya T
    J Antibiot (Tokyo); 1990 Oct; 43(10):1278-85. PubMed ID: 2124209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of benzothiazolo[3,2-a]quinolone antibacterial agents.
    Chu DT; Fernandes PB; Pernet AG
    J Med Chem; 1986 Aug; 29(8):1531-4. PubMed ID: 3090265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antibacterial activity of 5- and 6-hydroxy substituted 4-aminoquinolines and derivatives.
    Meyer T; Lemcke T; Geffken D; Kaulfers PM
    Pharmazie; 2001 Sep; 56(9):691-5. PubMed ID: 11593987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
    Skar AG; Midtvedt T; Dahl O
    NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Microbiological evaluation of the antibacterial activity of cefotaxime in comparison with other cephalosporins].
    Concia E; Marone P; Verani D; Marino P
    Boll Ist Sieroter Milan; 1982; 61(4):300-8. PubMed ID: 6100233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bacteriological and pharmacological properties of new cephalosporin antibiotics. I. Cephalothin. 2].
    Naumann P
    Arzneimittelforschung; 1966 Aug; 16(8):1099-104. PubMed ID: 4385598
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on the antibacterial effect of cephalothin].
    Ritzerfeld W; Stromberg H
    Arzneimittelforschung; 1966 Sep; 16(9):1219-21. PubMed ID: 4870013
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cephalothin in the antibiogram].
    Warnecke B
    Arzneimittelforschung; 1967 Dec; 17(12):1537-41. PubMed ID: 4387781
    [No Abstract]   [Full Text] [Related]  

  • 12. Cephalothin: antibacterial activity in vitro and treatment of infections in man.
    Altucci P; Sapio U; Varone GL
    Chemotherapy; 1967; 12(2):89-100. PubMed ID: 4383219
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and antibacterial activity of a new series of tetracyclic pyridone carboxylic acids.
    Jinbo Y; Kondo H; Inoue Y; Taguchi M; Tsujishita H; Kotera Y; Sakamoto F; Tsukamoto G
    J Med Chem; 1993 Sep; 36(18):2621-6. PubMed ID: 8410974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-3578, a new broad spectrum parenteral cephalosporin exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Synthesis and structure-activity relationships.
    Yoshizawa H; Itani H; Ishikura K; Irie T; Yokoo K; Kubota T; Minami K; Iwaki T; Miwa H; Nishitani Y
    J Antibiot (Tokyo); 2002 Nov; 55(11):975-92. PubMed ID: 12546419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antibacterial activity of the 4-quinolone-3-carboxylic acid derivatives having a trifluoromethyl group as a novel N-1 substituent.
    Asahina Y; Araya I; Iwase K; Iinuma F; Hosaka M; Ishizaki T
    J Med Chem; 2005 May; 48(9):3443-6. PubMed ID: 15857152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cephalosporin 3'-quinolone esters with a dual mode of action.
    Albrecht HA; Beskid G; Chan KK; Christenson JG; Cleeland R; Deitcher KH; Georgopapadakou NH; Keith DD; Pruess DL; Sepinwall J
    J Med Chem; 1990 Jan; 33(1):77-86. PubMed ID: 2153215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro activity of pefloxacin compared to other antibiotics.
    Yourassowsky E; Van der Linden MP; Crokaert F; Glupczynski Y
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():19-28. PubMed ID: 3086279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of a series of parenteral 3'-quaternary ammonium cephalosporins.
    Brown RF; Kinnick MD; Morin JM; Vasileff RT; Counter FT; Davidson EO; Ensminger PW; Eudaly JA; Kasher JS; Katner AS
    J Med Chem; 1990 Aug; 33(8):2114-21. PubMed ID: 2115587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [5,7-Dichloro-8-hydroxy-quinoline derivatives with antibacterial and antifungal activity].
    Carissimi M; De Meglio PG; Ravenna F; Riva G
    Farmaco Sci; 1969 May; 24(5):478-99. PubMed ID: 4979903
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and structure-activity relationships of novel arylfluoroquinolone antibacterial agents.
    Chu DT; Fernandes PB; Claiborne AK; Pihuleac E; Nordeen CW; Maleczka RE; Pernet AG
    J Med Chem; 1985 Nov; 28(11):1558-64. PubMed ID: 3934382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.